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Hospitals across the country have been under increasing pressure to cut costs,
but Maryland’s new Global Budget agreement with CMS has put a spotlight on the
state’s hospitals which may feel as though they are the subject of significant scrutiny
as they make efforts to comply with the agreement. Peter Parvis is a lawyer who
represents hospitals, and other health care organizations on corporate and health
care regulatory matters. Here he explains Maryland’s new hospital reimbursement
agreement with CMS and implications for healthcare services provided both in
hospitals and in the community.
Background
Maryland is the only state where hospitals are not
reimbursed for Medicare covered patients using the
inpatient (diagnostic-related group) and outpatient
prospective payment systems. The State of Maryland
has operated its acute care hospitals under a unique
statewide rate regulated system (“the waiver”) since
1977, under which Medicare paid acute care hospitals
at rates set by a state agency—the Health Services
Cost Review Commission (HSCRC)—instead
of making payments under traditional Medicare
methodology. At around that time, waivers to
Maryland and a few other states were granted by CMS
to allow them to experiment with setting hospital
rates. In order to secure the waiver, rates at each hospital in Maryland had to be
approximately the same for all payors: Medicare, Medicaid, commercial insurers,
private payors and the uninsured (hence the term “All Payor”). Each hospital’s
payment rates were based on historical cost data, the health status of the patient
population served, and the level of uncompensated care provided to that population.
In order to maintain the waiver, the state was required to keep the growth in Medicare
Cont. on page 2
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Global Budget Revenue and Population Health: Maryland's Response to
the New Model Agreement with CMS
Cont. from page 1
payments per inpatient case below the
growth of inpatient Medicare costs
nationally.1
For over 30 years, using this all
payor model, Maryland was able to
successfully control the growth in per
admission hospital costs relative to
the nation. While the system worked
well for three decades, incentives
established by the waiver, as well
as hospital efforts toward better
population health (consistent with the
Affordable Care Act), pushed hospitals
to provide more outpatient care. This
change in the site of care increased
the intensity and costs of inpatient
services. As a result, Maryland was
unable to keep its cost growth rate
below the national average.
The New Waiver
Facing the reality that it could
not continue to meet the statutory
requirement to maintain its waiver,
the State negotiated for a replacement
for the waiver.2 The five-year Model
Agreement became effective January
1, 2014 and ends on December 31,
2018.
The Model Agreement is essentially
a cap on the increase in per capita
hospital expenditures. Under the old
model, the focus was on controlling
increases in Medicare inpatient
payments per case. However, the
new model “focuses on controlling
increases in total hospital revenue per
capita.”3 Under the new methodology,
the Commission prospectively
establishes a fixed annual revenue cap
for each hospital.
The Challenge for Maryland:
Controlling Utilization
The cap requires Maryland hospitals
to control hospital spending on a per
capita basis for both Medicare and all
other patients. Since Medicare pays
a much greater portion of the cost

of uncompensated care in Maryland
than in the rest of the country, hospital
charges in Maryland to Medicare
patients are generally higher than
Medicare payments in the rest of the
country. While Maryland hospitals
charge all patients, regardless of the
payor, the same rates, elsewhere,
hospitals get paid a fixed amount (with
variances for labor costs and various
other add-ons) for each Medicare
admission, emergency department
visit, or outpatient service depending
on its coding. That payment is
frequently lower than payments by
other insurance despite the fact that
Medicare beneficiaries use hospital
care at disproportionately higher
levels. Maryland hospitals charge for
the services used at approved rates
per unit of service. As a result, the
only way Maryland could achieve
the necessary results for the new
Model would be to control hospital
utilization. The issue was, how?
The State’s response was a new total
revenue approach. Trying to save
money by paying less for each service
on a per service basis—the model
Medicare uses everywhere else and
for physician services—ends up with
providers providing more services
to make up for reduced revenue per
case/visit/test. Maryland tackled
revenue reduction by capping the total
revenue each hospital could collect
in any given year through one of two
similar mechanisms—Total Patient
Revenue (basically for rural or smaller
hospitals); or Global Budget Revenue
(GBR, for every other hospital). A
hospital’s total revenue in any year
is set in advance. It is adjusted for
increases in population in its defined
service area. If its market share
increases in its service area (the goal
of every marketing effort by every
hospital everywhere else), it does not
get to keep the increased revenue.
Under the GBR, hospitals are
encouraged to jump start population
health efforts to provide more care

outside the walls of the hospital
setting, as long as that care is likely
to reduce hospital utilization and cost
—whether in the E.D., outpatient, or
inpatient admissions.4 The challenge
is stark—how to get physicians,
who refer patients, and the patients
themselves to accept as a premise
that “Less is More.” Worse, the
federal government has a panoply of
statutes that are designed to prevent
the payment of financial incentives
to physicians to reduce services to
Medicare patients (generally called
gain sharing), and the State to date
has not received a waiver from these
statutes.5 Moreover, a hospital gets
no credit for the simple expedient of
shifting services outside the hospital
setting. Any such attempt has to be
reported and results in a reduction of
the GBR total revenue so that total
costs do not increase when expensive
hospital services are moved to less
expensive non-hospital settings.
Under Maryland law, hospitals
must charge every patient for all
services used at rates approved by the
Commission (within corridors for over
and undercharges). It would seem
that providing less service to keep
costs down would reduce utilization,
but it is not that simple.6 The GBR is
also tied to other initiatives such as
to reduce readmissions to the hospital
within 30 days, to reduce hospital
acquired conditions and to reduce
potentially avoidable utilization.
Therefore, hospitals are punished
financially if they reduce the level of
services but there is a readmission
within 30 days or a hospital acquired
condition.
The challenge is to reduce utilization
in a system where every other player
in the health care industry is incented
to provide more volume to generate
more revenue. The task is enormous,
especially given that the Commission
only regulates hospitals and not
physicians. Hospitals have engaged
in a wide variety of efforts to improve
care at the community level, using
caseworkers to follow the patient
post discharge, creating programs

focused on high utilization diseases
(diabetes, COPD, and hypertension
are favorites), establishing outreach
programs (frequently involving
non-medical or volunteer personnel)
as well as medical home projects,
integrated case management intended
to avoid duplication as a result of
lack of information, and efforts to
get the patient invested in their own
healthcare. However, since federal
and State laws meant to prohibit
undue influence by hospitals over
referring physicians remain in effect,
it is difficult to financially incentivize
physicians and other providers to do
less. Of course, the State argues that
the goal is not to do less, but only to
eliminate services that may not be
necessary for the well-being of the
patient. Regardless of the view, “less
is more” is not universally accepted.
As a result, the total spending
per Medicare beneficiary presents
problems, which was foreseeable in
that the State only regulates hospital
revenue, and hospital revenue is not
the majority of health care spending.7
Since other provider costs are paid in
the same manner in Maryland as in
the rest of the country, utilization is
the issue in controlling these costs,
but unlike GBR for hospitals, there is
no financial approach to incentivize
all of the providers to work to reduce
utilization.8 The jury is still out on
the new Model and on GBR, but the
results have been promising in the
first two and a half years of the new
Model Agreement, at least as far as
controlling the increase in hospital
spending per capita, reducing the
Hospital Acquired Conditions Rate,
and producing Medicare savings (over
$300 million in the first two years).
While challenges remain, the State
is supposed to apply for a Phase II
five-year Model in 2017, which at a
minimum is supposed to cover more
services, with the goal of covering all
healthcare services.
Peter P. Parvis, J.D., Principal
Miles & Stockbridge P.C.

ENDNOTES
Under section 1814(b)(3) of the Social
Security Act; the statutory requirement
focused on the rate of increase in
Medicare payments to Maryland vs. the
rest of the country.
1

The HSCRC negotiated for this waiver
replacement with the Centers for
Medicare and Medicaid Innovation, an
entity under the Centers for Medicare
and Medicaid Services that was created
by the Affordable Care Act.
2

It requires the State to keep its increase
in cumulative annual all-payer per
capita total hospital revenue growth
for Maryland residents receiving care
at regulated Maryland hospitals to less
than or equal to Maryland’s ten-year
growth in gross state revenue.
3

The Commission explains: GBR and
TPR agreements prospectively establish
a fixed annual revenue cap for each
hospital to encourage them to focus on
care improvement and population-based
health management. From Report to the
Governor FY 2015. The HSCRC is in
the process of putting all hospitals on
the GBR.
4

These waivers are available for
accountable care organizations under the
Medicare Shared Savings Programs.
5

The HSCRC’s premise is that
all hospitals have to do is reduce
unnecessary utilization, which includes
readmissions, potentially preventable
conditions and hospital acquired
conditions.
6

7

At $972 billion in 2014, it is the biggest
single expenditure, compared to $802
billion for physicians, dentists and other
professional care; $400 billion for drugs
and supplies, and $389 billion for home
health and nursing home care nationally
in 2014. Medicare accounts for 20%
of total healthcare spending. Source:
National Health Expenditure 2014
Highlights.
The HSCRC has been working with
hospitals and other constituencies to
develop approaches that will permit
hospitals to incentivize physicians
to participate in utilization reduction
approaches, and to present its proposal
for the 2019-2023 time frame, but those
have not yet been formalized.
8

Mid-Atlantic Ethics Committee Newsletter 3

INTRODUCING … DAVID MOLLER, DIRECTOR OF HEALTH
CARE ETHICS, ANNE ARUNDEL MEDICAL CENTER
David Wendell Moller arrived at Anne
Arundel Medical Center on June 1
to develop a program in health care
ethics. He comes to Maryland after a
long bioethics career in the Midwest.
We share his brief bio here by way
of introduction, and hope you join us
in welcoming him back to the East
Coast and to our health care ethics
community.
David earned his PhD in
Sociomedical Sciences from
Columbia University. He spent
twenty years at Indiana University
where he was a faculty member
in the Schools of Liberal Arts and
Medicine. He was one of the core
medical ethics faculty members at
IU, and directed the community
outreach and educational programs
for the palliative care team at
Wishard Health Services (now
Eskenazi Health). While at
Indiana University he received the
system-wide President’s Award for
Distinguished Teaching and the
Outstanding Resident Faculty Award,
as well as numerous Trustees Awards
for Teaching Excellence. He most
recently served as Senior Director
of the Office of Human Values at
Truman Medical Center in Kansas
City where he pioneered an innovative
curriculum in diversity and cultural
competence for internal medicine
residents, which included home visits
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to hospice patients living in the inner
city. He has lectured extensively in
international and national settings and
has published five books on end-oflife care, which have been reviewed as
“breaking new ground,” and “destined
to become a landmark in the death
and dying literature.” His most recent

work is exploring what it is like to
live and die in urban poverty and the
challenges providers face when caring
for vulnerable populations that live
and die at the margins of society.
David’s plans for program
development at AAMC are focusing
on “bringing clinical ethics upstream,”
whereby ethics awareness and

capability can be more broadly
disseminated in patient care. This
includes implementing an ethics
screening for all patients admitted
into the hospital so as to identify
issues earlier. A contingent of “ethics
ambassadors” are being identified and
trained and will be present on each
unit throughout the hospital to assist
in identifying and resolving issues
related to clinical conflict earlier and
more systematically. In addition,
he is working at establishing Unit
Based Ethics Rounds (UBER),
whereby the ethics team conducts
hour-long, weekly rounds for
each of the relevant units—on the
unit itself. The program is being
developed with explicit concern for
addressing issues related to moral
distress, compassion fatigue, and
demoralization of clinical caregivers
in addition to its focus on clinical
conflict resolution.
Born in New York City and
having spent so many years in
the Midwest, David is delighted to
be returning to the East Coast, and
in the interest of full disclosure, he
must declare that he is a diehard NY
Yankees fan, which has been a difficult
thing lately, as in recent years the
Yankees have performed in most “unYankee-like” fashion.

MY PATIENT
By Suzanne Minor, MD, FAAP*
Reflective MedEd Blog
This essay was posted on August 9, 2016, on the Reflective MedEd blog, which
is supported by the Ralph P. Leischner, Jr., MD, Department of Medical Education
at Loyola University Chicago Stritch School of Medicine. It is published here with
permission. To read other entries or to submit your own blog post, visit https://
reflectivemeded.org/.
The student used the phrase “my patient” six times during the brief patient
interaction: “I don’t like my patients to not exercise.” “I like it when my patients
eat healthy.” “I like it when my patients take their medications” and so on. Many
students use this phrase occasionally, but this was striking. I wondered what his
motivation was. Was he nervous? Or did he think the patients were his? After the
interaction, I debriefed with him, asking him what went well and what he could improve. He did not bring up his use
of “my patient” so I did. He was unaware of his saying “my patient” and could not reflect on why he was doing so. I
asked him what he thought this phrase might mean to the patient.
“The patient,” he queried, “what does that have to do with it?” I was frustrated, somewhat aghast that this thirdyear student, steeped in patient-centered interviewing throughout his first two years of school, missed that the patient
had something to do with their own care and that the phrase “my patient” might claim ownership of another person or
their attributes, such as soul, physical being, or responsibilities…
I asked him, “Who is responsible for the patient’s care?”
“I am,” he responded quickly. Specifically relating the discussion to patient autonomy from his clinical skills
training, he voiced some understanding that the hypothetical patient shared some responsibility for her care, but could
not imagine this actual patient playing a chief role in their well-being as he felt that was his role as the physician-intraining.
I left the discussion unsatisfied and shared the interaction with a fellow health educator that evening. She said that
as a social worker it was important to avoid this phrase because it meant that person is the only person responsible for
the patient’s care, negating the patient’s ownership for her care as well as the interprofessional team members working
to improve the patient’s well-being, such as the social worker, nurse, dietitian, and physical therapist.
I then discussed “my patient’ with residency faculty. One physician detailed orienting residents that the patients
were their patients rather than her patients, impressing on residents that they were responsible for the patient’s care,
not her. “My patient” represented accountability and ownership of the role of physician.
Not long after the “my patient” interaction in clinic, I said goodbye to my patients. Yes, “my patients!” I had
been seeing some of them for 10 years; it was difficult to say goodbye. I completely accepted responsibility for my
part of their care and strived to not claim responsibility for their roles. These patients were a part of my life. It felt
incomplete and disrespectful to call them “the patients” rather than “my patients.” I think this was a way of honoring
our relationship. It felt uplifting to put to words this connection to another human being, however humble it may be.
I felt like I’ve come full circle, from ownership to relationships.
I think this phrase, “my patient,” has struck me so because of this value of connecting to others. Just as I
encouraged the student to open his mind to other meanings, I can open my mind to the intricacies of our language.
I love that I can continue to evolve as a physician, educator, and person. As much as possible, my goal now is to
empower the patient by helping them to take ownership for their care and well-being and to empower the learner to
be the patient advocate as well as empowerer. I want to empower patients to take responsibility for their well-being,
their care, their bodies, their selves.
*Dr. Minor is the Director of Clinical Faculty Development and an Associate Professor at the Florida International
University Herbert Wertheim College of Medicine.
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HOPKINS PERFORMS FIRST HIV+ TO HIV+ ORGAN
TRANSPLANT
Last Spring, Hopkins
performed a first
in organ transplant
medicine: an HIVpositive dead donor
provided a liver and
kidney to two HIV-positive recipients.
Transplanting organs from HIVpositive donors was banned in the
U.S. in 1984. Over the years, concerns
escalated about the lack of ethical
justification for letting HIV-positive
patients awaiting an organ transplant
die when they could safely receive an
organ from an HIV-positive donor.
The 2013 HIV Organ Policy Equity
(HOPE) Act, signed in 2013, ended
the ban on using HIV-positive donor
organs. However, it took another three
years before the United Network for
Organ Sharing (UNOS) approved
the first hospital to conduct such
transplants. That honor went to

Hopkins, perhaps in part due to
the advocacy of Hopkins surgeon
Dorry Segev in getting the HOPE
Act drafted and passed (Cohn,
2016). Given breakthroughs in
anti-viral medications to suppress
the HIV virus, most HIV-positive
donors have sufficiently low viral
loads to make donation safe for an
HIV-positive recipient. Transplantation
of an organ from an HIV-positive
donor into an HIV-positive individual
will be done under a research protocol
requiring, among other things, that
the donor and recipient be on similar
anti-viral drug regimens. Research
protocols are currently being
developed to allow living HIV-positive
individuals to donate organs to other
HIV-positive individuals. Providing
these transplants under research
protocols will allow comparison
of outcomes between HIV-positive

individuals transplanted with organs
with and without prior exposure to
the HIV virus. One concern is that the
organ recipient could contract a more
aggressive strain of the HIV virus,
but the criteria for matching donor
and recipient incorporates safeguards
to minimize this risk. Although the
number of HIV-positive donors will
remain relatively small in the near
future, it will grow over time, and will
effectively shorten organ wait times
for everyone.
REFERENCES
Cohn, M. (March 30, 2016). Johns
Hopkins performs first transplants
between donors, recipients infected with
HIV. The Baltimore Sun, Available at
http://www.baltimoresun.com/health/bshs-hiv-transplant-20160329-story.html.

HORIZON FOUNDATION ANNOUNCES HOWARD COUNTY
SPEAK(EASY) PROGRAM
This article was adapted from a press release available at: http://www.thehorizonfoundation.org/horizonfoundation-announces-speakeasy-howard-campaign/.
The Horizon Foundation has announced the launch of Speak(easy) Howard, a new campaign that aims to encourage
Howard County residents to take two critical first steps in planning for end-of-life care: have a conversation about
health care wishes with loved ones and identify a health care proxy who can communicate these wishes. The campaign
kicked off June 23, 2016 with the launch of a community collaborative made up of nearly a dozen organizations.
Collaborative participants—including faith groups, health care providers, community centers and others—will commit
one year to learning and implementing best practices in end-of-life care planning. The collaborative will receive
guidance and support from experts with The Conversation Project and the Institute for Healthcare Improvement. In
2017, the Horizon Foundation will launch a countywide outreach and promotion campaign for Speak(easy) Howard
to expand the collaborative’s efforts to all individuals in Howard County. An important goal is to increase the number
of people who have designated their health care proxy, a trusted person who will make health care decisions if they
are unable to communicate those decisions themselves. Another important goal of this effort is to ensure doctors can
connect with chosen health care proxies and learn each person’s care decisions so these wishes can be respected.
Horizon is partnering with the Howard County government and Maryland’s official health information exchange,
Chesapeake Regional Information System for our Patients (CRISP), to establish an electronic registry that will allow
individuals to designate their health care proxy online, and have that information easily accessible by hospital and
medical providers statewide. For more information, visit http://speakeasyhoward.org/.
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JAHI MCMATH UPDATE
In December, 2013, then-thirteen year old Jahi McMath was pronounced dead after physical exams and
confirmatory criteria indicated irreversible cessation of brain function. Her family sought legal intervention to
maintain Jahi on ventilator support, along with artificial nutrition/hydration. Her body was ultimately moved across
country from California, and currently resides in a facility in New Jersey, which allows an exemption from declaration
of death based on neurologic criteria for those who have a religious belief that if a person’s heart is still beating, the
person is still alive. Jahi’s parents claim to have new evidence that Jahi has brain function precluding a brain death
determination.
Complaints filed by the McMath family in a medical malpractice action against Oakland Children's hospital include
opinions from a pediatrician with expertise in brain death who reviewed Jahi’s medical records, magnetic resonance
imaging (MRI) and magnetic resonance angiography (MRA) scans done in September, 2014 (about 10 months after
Jahi’s anoxic brain injury), and 22 videotapes of Jahi’s movements. The pediatric neurologist concluded that Jahi
does not meet brain death criteria. Specifically, the MRI reportedly showed vast areas of the brain that are structurally
preserved (including areas in the cerebral cortex, basal ganglia and cerebellum), and the MRA showed intracranial
blood flow. Moreover, Jahi reportedly underwent menarche and developed breasts since her brain injury. If this
were true, it would demonstrate hormonal interaction between the hypothalamus, pituitary gland, and ovaries that
demonstrates some level of brain function. Lastly, Jahi is reportedly able to respond intentionally at times to verbal
commands (Pope, n.d.). Those doubting the assertion that Jahi does not now meet brain death criteria point out that
the scans and videotapes have not been released for others to view, and that she may well have reached menarche
before her injury (i.e., continued menstruation after a brain death determination does not signify brain function at
odds with a brain death diagnosis). Given that confirmatory testing initially done (and repeated
before Jahi’s transfer out of California) indicated that Jahi had irreversible and complete loss of
brain function and thus met legal criteria for death, if new data reveal otherwise, this may have
widespread implications for how death is defined in the U.S. and elsewhere.
REFERENCE
Pope, T. (n.d.). Jahi McMath: A Dispute over Brain Death. Available at http://www.thaddeuspope.com/jahimcmath.html.

NIH'S CENTERS OF EXCELLENCE IN PAIN EDUCATION
(COEPE) MODULES
The National Institutes of Health
Pain Consortium has funded 11
health professional schools as
designated Centers of Excellence
in Pain Education (CoEPEs). The
CoEPEs will develop, evaluate,
and distribute pain management
curriculum resources for schools
training health care professionals
(including medical, dental, nursing,
and pharmacy schools). The awardees
are University of Alabama at
Birmingham, University of California,
San Francisco, Harvard University,

University of Connecticut, University
of Iowa, Johns Hopkins University,
University of Pennsylvania,
University of Pittsburgh, University
of Rochester, Southern Illinois
University Edwardsville, and the
University of Washington.
The first CoEPE module, released
July 20, 2016 from the University of
Pittsburgh, features a case study of
“Edna,” an older adult with chronic
low back pain. (To access this and
other CoEPE modules, visit https://
painconsortium.nih.gov/NIH_Pain_

Programs/CoEPES.html.) Sponsors
of NIH’s Pain Consortium include the
National Institute on Drug Abuse, the
National Center for Complementary
and Integrative Health, the National
Institute of Dental and Craniofacial
Research, the National Institute
of Nursing Research, the National
Institute of Neurological Disorders
and Stroke, the Office of Behavioral
and Social Sciences Research, and
the Office of Research on Women’s
Health.
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CASE PRESENTATION
One of the regular features of this Newsletter is the presentation of a case considered by an ethics committee and an
analysis of the ethical issues involved. Readers are both encouraged to comment on the case or analysis and to submit
other cases that their ethics committee has dealt with. In all cases, identifying information about patients and others in the
case should only be provided with the permission of the patient. Unless otherwise indicated, our policy is not to identify
the submitter or institution. We may also change facts to protect confidentiality. Cases and comments should be sent to
MHECN@law.umaryland.edu, or MHECN, Law & Health Care Program, University of Maryland Francis King Carey
School of Law, 500 W. Baltimore St., Baltimore, MD 21201.
CASE STUDY FROM A TERTIARY CARE HOSPITAL
Mrs. R. is a 96 year old female who was admitted from home to a community hospital with pneumonia. She was living
at home before that with increasing assistance from paid caregivers. There, she was treated in the community hospital's
ICU for three days before being transferred to a larger hospital, where she remains intubated in the ICU, on a ventilator,
non-communicative. She has a feeding tube in place and is transitioning to intermittent dialysis from continuous dialysis
to manage her high blood volume. Her blood pressure is being supported by medication. General surgery is consulted
to assess for tracheostomy placement. Mrs. R has a living son (K, who lives in state) and a daughter (H, who lives in a
distant state) involved in her care. H. wants to maintain life support and is in favor of the trach. She believes her mother
is a fighter and would want to live. K. disagrees. He states that while his mother never discussed end-of-life preferences
with them, and didn't complete an advance directive, she did not like to see people in wheelchairs, and was uncomfortable
when her husband spent time in the nursing home (he died 4 years prior). K. describes his mother as "lively," she enjoyed
casinos, going out, and keeping her appearance. He feels confident that "she would never want to live like this hooked up
to all these machines." But to avoid conflict, he defers to H's wishes. The team thinks it's nearly certain that Mrs. R. will
not leave the ICU. The surgical team requests an ethics consultation to inform whether they should proceed with the trach.
COMMENTS FROM ETHICS
COMMITTEE MEMBERS
This case demonstrates what
happens with families in hospitals
every day. Medical decision making
can be extremely difficult when there
are differences in opinion among
family members and little or no
previous discussions have taken place
to communicate wishes. Uncertainty
frequently happens and this case is the
perfect example of why care planning
is so important and how hospital
ethics committee members facilitate
conversations and collaborate with
families to assist them in medical
decision making. Since Mrs. R, a
widow, does not have an advance
directive, Maryland surrogacy law
dictates that her children have equal
say in all decision making (https://
www.oag.state.md.us/Healthpol/
HCDA.htm).
In this case, there are at least four
competing perspectives regarding
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treatment, the clinical team, Mrs. R
and her two children. What does each
perspective believe is the best for Mrs.
R.? For the clinical team, a treatment
plan which promotes beneficence
while avoiding maleficence. For
Mrs. R., in the absence of an advance
directive, it is difficult to assess her
true perspective. This leads to the
competing and complex perspective of
her two children. Her son articulates
his belief that she would want a
lively quality of life not dependent on
machines while her daughter expects
her mother to fight to live at all costs.
These competing narratives warrant
open discussion and examination.

team to review Mrs. R.’s illness with
the family and to address the risks,
benefits and probable outcome(s)
for Mrs. R. and to answer any of the
children’s questions.

In a patient and family centered model
of care, it is critically important that
a family meeting be conducted which
would provide an opportunity for the
expression and discussion of these
competing perspectives. Since the goal
for this meeting is to help the children
facilitate a plan of care for their
mother, it is important for the clinical

After the medical information is
presented, the discussion would move
to other aspects of the patient’s values,
beliefs and spiritual background. This
helps frame the difficult question of
quality of life for someone who can
no longer speak for herself. With
this framework, her children would
then be encouraged to express their

This supportive conversation would
include the patient’s advanced age
and medical history, her current
condition, current and proposed
interventions including details about
the tracheostomy, ventilator, and
feeding tube. It is also paramount that
members of the clinical team are able
to address specific questions regarding
care, treatment and potential prognosis
in a manner that family members can
understand.

thoughts and feelings and to identify
areas of agreement and disagreement
with respect to their mother’s quality
of life. The family meeting would
include the opportunity for Mrs.
R.’s children to discuss amongst
themselves, and with any other family
they would like to include, the options
for this patient. It is not unusual after
a family meeting for a follow up
conversation to address any questions
that may have come out of the first
meeting. The result of this meeting
would hopefully lead to an agreement
between both children on how to
proceed with the patient’s medical
care.
Unfortunately, not all families come
to an agreement even with extensive
discussions. While not completely
the scope of this current response, if
disagreement persisted, several new
questions would arise. One issue
would be if one of the children agreed
to abdicate their right for equal say in
decision making, the other child could
become the patient’s sole surrogate
decision maker. Clear documentation
of an affidavit of surrogacy should
then be done and care would proceed
based on that child’s decisions.
Another outcome of a disagreement
could be the failure of either child to
forgo their decision making right. This
would likely require more in-depth
conversations and family meetings. If
disagreement persisted, petitioning for
guardianship could be done to allow
the courts to weigh in on who should
be guardian. This process can be
onerous and lead to further acrimony
among family members. Finally,
if clinical teams fundamentally
disagree with decisions that have
been made in a patient’s plan of care,
documentation and discussions of
futility may happen. The concept of
medically ineffective treatment, i.e.
futility, is incorporated in Maryland
law (Sabatino, 2010), and informed by
ethical guidelines (Bosslet et al, 2015;
Kon et al., 2016). Families must still
be included in these discussions and
have to be notified of the decision to

withhold or withdraw treatment based
on futility.
University of Maryland Upper
Chesapeake Health Ethics
Committee Members:
Karen Goodison, MS,
RRT-NPS, RPFT
Jamie Kelly, LCSW
Angela Poppe Ries, MD
Allen Siegel, OFS, MA
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COMMENTS FROM A
PHYSICIAN ETHICS
COMMITTEE CHAIR
The immediate question being
asked regarding tracheostomy is
really fairly straightforward, but
there are much larger issues lurking
in the background. In my opinion,
looking at the question through the
eyes of a recovering adult intensivist,
the question of tracheostomy can
be answered from a straightforward
medical risk-benefit viewpoint,
based on the ethical principles of
beneficence and non-maleficence. The
endotracheal tube which is already in

place is an acceptable way to maintain
mechanical ventilation. While “early
trach” is sometimes recommended
for a variety of reasons, it is not
mandatory. Since the patient is not
expected to survive the ICU stay, it
is difficult to justify trach as being
beneficial at all, and there certainly are
risks to the procedure. Thus, it seems
medically prudent to maintain a wait
and see attitude, as tracheostomy may
never be required if the patient dies of
her underlying disease process within
the next few weeks. Time is also
gained for potential resolution of the
underlying end-of-life issues.
The larger issue is how did R wind
up on invasive life support measures
in the first place, and why is there
dispute about her wishes regarding
end of life care? Rather than limit
our opinion to placement of the
tracheostomy, I believe it is imperative
to question the current course of
treatment R is enduring. We know
that R and her children never had
“The Conversation.” Apparently
she never had it with her physician
either, although we are not specifically
told that her primary doctor was
appropriately contacted—something
that seems to get overlooked
more and more in our fragmented
medical delivery system. Clearly
the uncertainty about R’s wishes
represents a failure on many levels,
not just medical. If she filled out a
financial will, why didn’t her lawyer
introduce a medical directive too?
We freely talk about how to spend
down assets or distribute someone’s
possessions after they die, so why
not how they want to spend their last
days? Religious communities can also
do a better job at facilitating end of
life conversations with families.
Since there is no advance directive
or medical agent named, R’s children,
since her spouse is dead, are now her
surrogates and each has equal power
under the law. Unfortunately, it is
common that there is disagreement
Cont. on page 10
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Case Presentation
Cont. from page 9

basis for the entire informed consent
process.

between children as in this case.
Her son, K, provides insight into his
mother’s personality, believes his
mother would not want to die this
way, and does not want to proceed
with tracheostomy. His sister H,
however, claims that her mother is
a fighter and wants to proceed with
tracheostomy. In order to keep peace
in the family, K is deferring to H, as
is his right. One can only speculate
about the psychologic dynamics
leading to their difference in opinion.

Some may fear that such an
interpretation of patient autonomy
places us on the slippery slope to
paternalism. However, I believe this
interpretation is entirely consistent
with the current acceptance of
“shared decision-making” as the
model for determination of goals of
care. In too many cases, however,
the physician’s share of the decision
is almost totally subordinate to the
patient or surrogate. The above
interpretation of autonomy should
help even this balance.

As tracheostomy is medically
unnecessary at this time, why
were the children asked to provide
informed consent for this procedure?
We can only speculate that H has
also informed the medical team
that R is to be a full code, and the
medical team is now asking, probably
by reflex instead of reasoning, for
tracheostomy (the ritual of PEG
tube placement having already been
performed). To be clear, even if R
is a full code at the moment, there
is no ethical obligation to offer
non-beneficial treatment and in my
opinion consent for a trach should not
have been requested.
We have now reached the point
where we must discuss autonomy.
There seems to be a common
perception in our society that
autonomy means that a patient, or
surrogate, has the right to determine
what treatments will be given,
and many physicians think they
are required to offer all possible
treatments, not just those that would
be beneficial to the patient. This is
one of the root causes of many of the
dilemmas clinicians face especially
when treating patients at end of life.
Rather than the right to determine
what treatments will be given,
autonomy is the right of the patient
to say “don’t do that to me.” It is
the right to say what you don’t want
done to your body, and is the ethical
10 Mid-Atlantic Ethics Committee Newsletter

Now that tracheostomy has
been deferred, it is time to resume
negotiations with the family regarding
goals of care. We have not been told
if Palliative Care has been involved;
if not, they should be consulted to
present their recommendations and
how they would care for R. Perhaps
there are other family members or
friends who would be willing to
participate and share their perceptions
of what R would want given her
current condition. During the family
meeting, which hopefully H will be
able to attend in person so she can see
her mother, I would review the ethical
principles involved, including the
physician’s obligation to advocate,
first and foremost, for their patient,
and to alleviate suffering, not cause
it. We need to make it clear to H
that withholding non-beneficial
treatments that simply prolong the
dying process does not mean that
we are withholding care. I would
inform H that R’s physicians do not
expect R to survive the ICU stay
even with the invasive treatments
being provided. Therefore, these
treatments are inherently nonbeneficial and medically ineffective,
as they will not prevent the death
of the patient from her underlying
disease but only prolong R’s death
and suffering, violating the principle
of non-maleficence. I would speak of
autonomy as the right of the surrogate
to put limitations on treatments

they think R would not want in her
current condition, but not the right to
require non-beneficial and harmful
treatments be given. The medical
team should present the treatment
options that they believe can benefit
and provide proper care for R, as well
as their recommendations. In this
way, surrogates can choose between
medically and ethically acceptable
treatments.
In the course of such negotiations,
questions of withdrawal and
withholding occur. While withdrawal
and withholding are considered
ethically and legally the same,
emotionally they are quite different.
If withdrawal is more than the family
or surrogate can bear, compromises,
such as no escalation of lifesustaining treatments including no
CPR, may be warranted. While not an
ideal resolution, as patient suffering
can still be prolonged, it certainly
provides some limits on medically
ineffective treatments which would
otherwise be given.
If negotiations fail, the last recourse
is to use the process stipulated in the
Health Care Decisions Act to declare
specific treatments to be medically
ineffective. It is beyond the scope
of this commentary to review this
process, other than to say it is an
option with which our physicians and
ethics committees should be familiar.
Lee Edward Schwab, MD, FCCP
Chair, Ethics Committee
Holy Cross Hospital
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CALENDAR OF EVENTS
OCTOBER
19 (4-6P)
Advancing Public Policy to Recognize and Support Family Caregivers. Sponsored by the Geriatrics and Gerontology
Education and Research Program and UM partners. Contact: rcornman@umaryland.edu.
20 (5:30-7P)
2016 Presidential Election Panel: The Affordable Care Act: Too Big to Fail? Sponsored by the Law & Health Care
Program, Maryland Carey Law, Ceremonial Moot Court Room, 500 West Baltimore St., Baltimore, MD. For more
information, contact vrowthorn@law.umaryland.edu.
20
Recovering Inside? Ethical Challenges in Correctional Mental health Care. Sponsored by the Department of Medical
Ethics & Health Policy, University of Pennsylvania, Philadelphia, PA. Visit: http://medicalethics.med.upenn.edu/
events/2016/10/20/recovering-inside-ethical-challenges-in-correctional-mental-health-care
24 (12-1:15P)
Johns Hopkins Berman Institute of Bioethics Seminar Series. Speaker: Susan Goold, MD, Professor of Internal Medicine
(School of Medicine) & Health Management and Policy (School of Public Health), University of Michigan. Feinstone
Hall, E2030, Johns Hopkins Bloomberg School of Public Health, 615 N. Wolfe St., Baltimore, MD. Visit: http://www.
bioethicsinstitute.org/education-training-2/seminar-series.
NOVEMBER
1
Challenges in Organ Donation & Transplantation, Third Interprofessional Forum on Ethics and Religion in Health Care.
Sponsored by the Institute for Jewish Continuity and UM Schools of Dentistry, Medicine, Law (MHECN), Nursing,
Pharmacy, and Social Work. Visit: http://www.law.umaryland.edu/mhecn.
4-7
Clinical Ethics Immersion, Sponsored by the Center for Ethics at MedStar Washington Hospital Center, Washington, DC.
Visit: http://www.medstarwashington.org/our-hospital/center-for-ethics/clinical-ethics-immersion/#q={}.
11-12
The 28th Annual Dorothy J. MacLean Fellows Conference on Clinical Medical Ethics, University of Chicago Law School,
Chicago, IL. Visit: http://MacLeanConference2016.eventbrite.com.
14-16
Bioethical Challenges in Neurogenomics from an Interreligious and Multicultural Perspective. Sponsored by MD Anderson
Cancer Center, Houston, Texas. For more information, contact cmgallagher@mdanderson.org.
28
Johns Hopkins Berman Institute of Bioethics Seminar Series. Speaker: Bob Arnold, MD, Professor of Medicine, Chief,
Section of Palliative Care and Medical Ethics, Director, Institute for Doctor-Patient Communication, University of
Pittsburgh. Chevy Chase Conference Center, Sheik Zayed Tower, Johns Hopkins Hospital, Baltimore, MD. Visit: http://
www.bioethicsinstitute.org/education-training-2/seminar-series.
28
Johns Hopkins Berman Institute of Bioethics Seminar Series. Speaker: Kimani Paul-Emile, PhD, JD, Associate Professor
of Law, Fordham University School of Law. Chevy Chase Conference Center, Sheik Zayed Tower, Johns Hopkins
Hospital, Baltimore, MD. Visit: http://www.bioethicsinstitute.org/education-training-2/seminar-series.
DECEMBER
12
Johns Hopkins Berman Institute of Bioethics Seminar Series. Speaker: John Wilbanks, Chief Commons Officer, Sage
Bionetworks. Chevy Chase Conference Center, Sheik Zayed Tower, Johns Hopkins Hospital, Baltimore, MD. Visit: http://
www.bioethicsinstitute.org/education-training-2/seminar-series.
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The Law & Health Care Program
Maryland Health Care Ethics
Committee Network
University of Maryland
Francis King Carey School of Law
500 W. Baltimore Street
Baltimore, MD 21201

The Maryland Healthcare Ethics Committee Network (MHECN) is a membership organization, established by the Law and
Health Care Program at the University of Maryland Francis King Carey School of Law. The purpose of MHECN is to facilitate
and enhance ethical reflection in all aspects of decision making in health care settings by supporting and providing informational
and educational resources to ethics committees serving health care institutions in the state of Maryland. The Network attempts to
achieve this goal by:
•

Serving as a resource to ethics committees as they investigate ethical dilemmas within their institution and as they strive to
assist their institution act consistently with its mission statement;

•

Fostering communication and information sharing among Network members;

•

Providing educational programs for ethics committee members, other healthcare providers, and members of the general
public on ethical issues in health care; and

•

Conducting research to improve the functioning of ethics committees and ultimately the care of patients in Maryland.

MHECN appreciates the support of its individual and institutional members. MHECN also welcomes support from affiliate
members who provide additional financial support.
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